Medicine Description glimepiride-plus 30 mg
Glimepiride Plus 30 mg tablet is a medication that combines glimepiride and pioglitazone to manage type 2 diabetes. Glimepiride, a sulfonylurea, acts primarily by stimulating the beta cells of the pancreas to increase insulin secretion. This action helps lower blood sugar levels post-meal. Pioglitazone, on the other hand, belongs to the thiazolidinedione class and functions by enhancing insulin sensitivity in muscle and adipose tissues, thus improving glucose uptake and utilization. Together, these two components work synergistically to achieve better glycemic control in patients with type 2 diabetes.
Indications and Uses of Glimepiride Plus 30 mg tablet
- Management of type 2 diabetes mellitus in adults
- Used when blood sugar levels are not adequately controlled with monotherapy
- Recommended for patients who require dual therapy to improve glycemic control
Side Effects of Glimepiride Plus 30 mg tablet
- Hypoglycemia
- Weight gain
- Fluid retention
- Headache
- Dizziness
- Nasal congestion
- Abdominal pain
- Possible risk of heart failure
Storage and Handling
Store Glimepiride Plus tablets in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use beyond the expiration date.
Patient Advice and Precautions
Monitor blood sugar levels regularly as advised by your healthcare provider. It is crucial to maintain a balanced diet and exercise regimen while on this medication. Be vigilant for symptoms of hypoglycemia, such as sweating, dizziness, or confusion, and discuss any significant changes in your health with your physician. Always consult your healthcare provider before making any changes to your treatment plan.